BE615395A - - Google Patents

Info

Publication number
BE615395A
BE615395A BE615395A BE615395A BE615395A BE 615395 A BE615395 A BE 615395A BE 615395 A BE615395 A BE 615395A BE 615395 A BE615395 A BE 615395A BE 615395 A BE615395 A BE 615395A
Authority
BE
Belgium
Prior art keywords
methyl
radical
denotes
indolyl
lower alkyl
Prior art date
Application number
BE615395A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication of BE615395A publication Critical patent/BE615395A/fr
Application filed filed Critical
Priority to BE615395A priority Critical patent/BE615395A/fr
Priority to GT196600427A priority patent/GT196600427A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BE615395A 1962-03-21 1962-03-21 BE615395A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BE615395A BE615395A (de) 1962-03-21 1962-03-21
GT196600427A GT196600427A (es) 1962-03-21 1966-05-02 Un compuesto de la serie indol y el procedimiento para sintetizarlo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE615395A BE615395A (de) 1962-03-21 1962-03-21

Publications (1)

Publication Number Publication Date
BE615395A true BE615395A (de)

Family

ID=193375

Family Applications (1)

Application Number Title Priority Date Filing Date
BE615395A BE615395A (de) 1962-03-21 1962-03-21

Country Status (2)

Country Link
BE (1) BE615395A (de)
GT (1) GT196600427A (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322787A (en) * 1964-09-25 1967-05-30 Merck & Co Inc Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
US3351630A (en) * 1964-02-28 1967-11-07 Merck & Co Inc Alpha-substituted-3-indolyl acetic acid compounds and processes for their preparation
US3376316A (en) * 1962-12-28 1968-04-02 Merck & Co Inc Lower alkyl gamma keto acid 2-pyranyl esters
US3471514A (en) * 1966-11-14 1969-10-07 Merck & Co Inc Process for alpha-(5-nitroindolyl-3)-alkanoic acids
US3501465A (en) * 1964-07-02 1970-03-17 Merck & Co Inc 3-indolyl lower aliphatic amines
EP0012957A1 (de) * 1978-12-20 1980-07-09 Roche Diagnostics GmbH Diagnostisches Mittel zum Nachweis proteolytischer Enzyme sowie als Chromogene hierfür geeignete Indoxyl- bzw. Thioindoxylester, Verfahren zu deren Herstellung sowie deren Verwendung zur Herstellung diagnostischer Mittel
WO1996025397A1 (en) * 1995-02-15 1996-08-22 Merck Frosst Canada Inc. Indole derivatives with affinity for the cannabinoid receptor
US11746087B1 (en) 2022-03-18 2023-09-05 Enveric Biosciences Canada Inc. C4-carboxylic acid-substituted tryptamine derivatives and methods of using

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3376316A (en) * 1962-12-28 1968-04-02 Merck & Co Inc Lower alkyl gamma keto acid 2-pyranyl esters
US3351630A (en) * 1964-02-28 1967-11-07 Merck & Co Inc Alpha-substituted-3-indolyl acetic acid compounds and processes for their preparation
US3501465A (en) * 1964-07-02 1970-03-17 Merck & Co Inc 3-indolyl lower aliphatic amines
US3322787A (en) * 1964-09-25 1967-05-30 Merck & Co Inc Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
US3471514A (en) * 1966-11-14 1969-10-07 Merck & Co Inc Process for alpha-(5-nitroindolyl-3)-alkanoic acids
EP0012957A1 (de) * 1978-12-20 1980-07-09 Roche Diagnostics GmbH Diagnostisches Mittel zum Nachweis proteolytischer Enzyme sowie als Chromogene hierfür geeignete Indoxyl- bzw. Thioindoxylester, Verfahren zu deren Herstellung sowie deren Verwendung zur Herstellung diagnostischer Mittel
WO1996025397A1 (en) * 1995-02-15 1996-08-22 Merck Frosst Canada Inc. Indole derivatives with affinity for the cannabinoid receptor
US11746087B1 (en) 2022-03-18 2023-09-05 Enveric Biosciences Canada Inc. C4-carboxylic acid-substituted tryptamine derivatives and methods of using

Also Published As

Publication number Publication date
GT196600427A (es) 1967-10-24

Similar Documents

Publication Publication Date Title
EP0442820B1 (de) Benzimidazo- und Azabenzimidazol-Derivate, Tromboxanrezeptorantagonisten, Verfahren zu deren Herstellung, Herstellungszwischenprodukte, diese enthaltende Zusammenstellungen
JPH0231079B2 (de)
EP1465880B1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
CA2304397A1 (fr) Derives de carboxamidothiazoles, leur preparation, les compositions pharmaceutiques en contenant
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
FR2890071A1 (fr) Nouveaux composes de l'indole
EP0465323A1 (de) Pyrimidinderivate, Angiotensin-II-Rezeptorantagonisten, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammenstellungen
EP0611766A1 (de) Polysubstituierte 2-Amidothiazole-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammenstellungen die sie enthalten und ihre Anwendung für die Bereitung eines Arzneimittels
BE615395A (de)
CH646967A5 (fr) Composes de pyranone et compositions pharmaceutiques les comprenant.
EP0620221A1 (de) 5-Acylamino-1,2,4-Thiadiazole als cholecystokin Antagonisten oder Agonisten
FR2560196A1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
FR2477150A1 (fr) Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
LU83576A1 (fr) Nouveaux derives du 4h-1,2,4-triazole,leur preparation,leur application comme medicament,les compositions les renfermant et les intermediaires obtenus
CH645370A5 (fr) Composes de pyranone et compositions pharmaceutiques les contenant.
EP0362006A1 (de) Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH648828A5 (fr) 7-acylindoles et leur utilisation pour la preparation de 7-acylindoline-2-ones.
EP0275762B1 (de) Indol-Carboxamid-Derivate und ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten
CH661512A5 (fr) 1-pyridyloxy-3-indolylalkylamino-propanols substitues et leur preparation.
EP0210893B1 (de) Benzamide, Verfahren zu deren Herstellung und deren therapeutische Anwendung
EP0476935A1 (de) Neue Indol- und Indolin-Verbindungen
CH620678A5 (en) Process for the preparation of a derivative of piperidine
BE806805A (fr) Composes d'acide tetrahydro-indazol-5-carboxylique, leurs sels metalliques et leurs procedes de production
JPS6040420B2 (ja) ３−アミノ−２−（５−フルオル−及び５−メトキシ−１ｈ−インド−ル−３−イル）プロパン酸誘導体類、その製法及び利用
EP0728755A1 (de) Thiophenverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen